2017 Philadelphia

Going Beyond with Non-Traditional Data Sources and Data Driven Analytics

 Sunday, April 02, 2017 – Tuesday, April 04, 2017, Loews Philadelphia


Challenges and Opportunities for the Future

William S. Hayes, PhD

Vice President of Data Science, Applied Dynamic Solutions

William Hayes, PhD Molecular Biology and Bachelors in Aerospace Engineering from Georgia Tech, is the VP of Data Science at Applied Dynamic Solutions, helping partners find more effective solutions to the big data and information heavy problems facing healthcare, bioPharma and other industries.

He was previously the CTO of Selventa (a personalized healthcare company using Systems Biology and OpenBEL for diagnostics development), Director of Decision Support in Biogen Idea R&D IT, Head of the Library & Literature Informatics Dept at Biogen Idea, and Head of Cross-Discovery Strategic Informatics at AstraZeneca focusing on data/text/image mining technologies and knowledge management.  Prior to that he was the Bioinformatics project lead for drug target-focused Text Mining. The expertise in text mining grew out of frustration with large-scale gene promoter analysis projects he performed at GlaxoSmithKline (GSK) where time in the library finding support for computational analyses took over 40X the time it took to run the computational part of the analyses.  Due to his experience at abusing supercomputing resources from rather large sequence analysis and other computationally intensive projects, he has also been very active in big data, semantic technologies, distributed computing and cloud computing.  His background in Aerospace Engineering and structural engineering of jet engines gives him an unusual viewpoint into computational molecular biology and a broad perspective on technical challenges and how to solve them.

Continuing Education Course

Workshop:  Overcoming Copyright Complexities in the Biopharmaceutical Industry

Michele L. Ayers and Stephen K. Garfield

Scientific content plays an important role in the business process of a biopharmaceutical corporation from the discovery research stage all the way to post-marketing pharmacovigilance, plus medical communication/information for marketing purposes, and occasionally even product liability litigation.  Journal articles, reference books, treatment guidelines, conference abstracts and posters, etc. all need to be readily available for all employees.  Awareness of the copyright implication and the best practices in content use and reuse are important factors in making appropriate decisions around the use of copyright protected materials. With an emphasis on all types of scientific content, key issues that affect employees are discussed. During the workshop, participants will have the opportunity to participate in a Q & A session as well as other interactive exercises. They will also receive a workbook to help with copyright questions long after the workshop has been completed.

Workshop Features:

1.  What is and is not copyright-protected?

2.  Fair use in a corporate environment

3.  When copyright permission is needed and how to obtain it?

5.  Social media concerns

6.  Issues specific to the biopharmaceutical industry including open access and text and data mining

Who Should Attend?

Biopharmaceutical professionals at all organization levels and anyone who wants to gain a better understanding of copyright law as applicable in a biopharmaceutical setting.


Michele L. Ayers, Senior Manager, Educational Services

Michele leads Copyright Clearance Center’s educational programs from development to delivery.  Through Copyright Clearance Center’s courses, webinars and events, thousands have improved their understanding of copyright and compliance best practices.  Michele is an invited speaker and educator on copyright law at companies and events worldwide. Since joining Copyright Clearance Center in 1999, Michele has developed a deep appreciation of the concerns and needs of content providers and users worldwide.

Stephen K. Garfield, 
Sr. Director, Client Engagement 

Stephen Garfield joined CCC in 2005 and is the Sr. Director Client Engagement. In this role, he has the dual responsibility for the annual renewals of all CCC’s corporate copyright and software licenses, as well as overseeing Strategic Client Engagement.  Together, these two roles give Stephen the opportunity to meet with and best understand customer needs and objectives to help drive future relationships in the corporate market.

Prior to joining CCC, Stephen spent eight years at Dow Jones as the Regional Manager, New England and Eastern Canada, of The Wall Street Journal, and 13 years at McGraw-Hill publishing working on Aviation Week & Space Technology magazine.

Monday Presentations

Keynote: Challenges and Opportunities for the Future 

William Hayes, Vice President of Data Science, Applied Dynamic Solutions


Health Care in the Era of Artificial Intelligence and Cognitive Computing 

Sean Grullon, Data Scientist, IBM Watson Health


Drug Discovery and Precision Medicine in the -Omics Era

Erin Wagner, Lead Statistician, BioStat Solutions, Inc. (BSSI)


Panel Discussion:

Literature Surveillance for Pharmacovigilance Tools and Systems for Driving Efficiency 

Moderator Timothy Hoctor, Vice President, Professional Services Corporate R&D, Elsevier

Sandra Bausback-Aballo Director, Vigilance, BTG plc.

Krisztina Debreczeni, M.D. Group Medical Director, Medical Safety Review, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb Co.

Gurdyal Kalsi, M.D., Chief Medical Officer, SVP Clinical Development & Medical Affairs, TissueGene


The Shape of Things to Come: Medical Devices and The Internet of Things (IoT) 

Susan Keckler, Senior Manager, Medical Communications, Teva Pharmaceuticals


Biopharma Intelligence from Partnering Conferences: A New Source of Business Development, R&D Strategy & Competitive Intelligence 

Sougato Das, Managing Director, Partnering & Business Development, Biotechnology Innovation Organization


The FDA Web Site/Improving Transparency 

Stephen Weitzman, Executive Director, MedDATA Foundation

Tuesday Presentations

Achieving SLA’s Mission

Roberto A. Sarmiento, SLA President-Elect, 2017


Data-Driven Research Intelligence in Biopharma

Peter Derycz, Chief Executive Officer and President, Reprints Desk


Panel Session:

Analytics in the Pharma Marketplace… and the Future

Dan Penny, Head of Market Intelligence, Springer

Ann Beynon, Manager, Solutions Specialists, North America, Clarivate Analytics

Nancy Muir, Director of Insights, MedImmune

Sara Rouhi, Director of Business Development, North America, Altmetric


Philosophy and Science of a Career Transformation from Information Professional to Informatics Professional 

Soraya Assar, Independent Consultant


Building to Empowerment: A New Library that Encourages User Independence

Saundra Ketner, Manager / Senior Librarian, Alkermes, Inc.

Carenanne Torrey, R&D Librarian, Alkermes, Inc.


Peeking Behind Curtains and Looking Under Rocks

Ed Silverman, Pharmalot Columnist and Senior Writer, STAT